Second annual JBC Methods Madness tournament begins next week
Calling all scientists! The Journal of Biological Chemistry’s second annual Methods Madness tournament is here.
Last year’s tournament came down to the wire with #TeamCryo scraping by #TeamMassSpec to be crowned the first ever #JBCMethodsMadness champion. Can #TeamCryo repeat this year? Will #TeamMassSpec get revenge? Will both be upset by a new contender? Now is your chance to decide who makes it through.
The madness begins on Monday. (See tournament schedule below). Submit your bracket by Sunday for a chance to win a $100 gift card.
Round 1: The Scientific 16
Vote for your favorite methods by participating in polls posted by @jbiolchem.
Monday, March 15
9 a.m. – #TeamMassSpec vs. #TeamFRET
2 p.m. – #TeamImmuno vs. #TeamXRC
Tuesday, March 16
9 a.m. – #TeamCryo vs. #TeamMachine
2 p.m. – #TeamiPSC vs. #TeamLiveCell
Wednesday, March 17
9 a.m. – #TeamPCR vs. #TeamChroma
2 p.m. – #TeamCloning vs. #TeamNMR
Thursday, March 18
9 a.m. – #TeamCRISPR vs. #TeamSuperRes
2 p.m. – #TeamOmics vs. #TeamOpto
All times Eastern.
A note about JBC methods
It's well known that science progresses by building on the shoulders of those who came before. That's especially true for papers that report new tools — genetic constructs, small molecules, model organisms, etc. — that can be directly used by colleagues to jump-start a new project or resolve a technical hurdle. And at JBC, our high standards for rigor and reproducibility mean that readers can trust published tools to work as promised.
— Lila Gierasch, JBC editor-in-chief
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Seeking the sweet spot to beat a pig parasite
Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.
Radioactive drugs strike cancer with precision
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.
Animals have used bioluminescence to communicate for millions of years
Despite its widespread occurrence, scientists don’t yet know when or where this phenomenon first emerged, or its original function.
Getting to the genetic basis of cardiovascular disease
Edwin G. Peña Martínez received a JBC Tabor award for associating the condition with mutations in noncoding sequences.
Microparticles safeguard vitamins and information
Scientists aim to use nanotechnology to combat malnutrition and improve medical recordkeeping in impoverished parts of the world.
Why AlphaFold 3 needs to be open source
The powerful AI-driven software from DeepMind was released without making its code openly available to scientists.